Clinical targeting of the TNF and TNFR superfamilies

被引：368

作者：

Croft, Michael ^{[1
]}

Benedict, Chris A. ^{[1
]}

Ware, Carl E. ^{[2
]}

机构：

[1] La Jolla Inst Allergy & Immunol, Div Immune Regulat, La Jolla, CA 92037 USA

[2] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, Lab Mol Immunol, La Jolla, CA 92037 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2013年 / 12卷 / 02期

基金：

美国国家卫生研究院;

关键词：

ANTI-CD40; MONOCLONAL-ANTIBODY; RELAPSED/REFRACTORY MULTIPLE-MYELOMA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COLLAGEN-INDUCED ARTHRITIS; CELL MATURATION ANTIGEN; B-LYMPHOCYTE STIMULATOR; VERSUS-HOST-DISEASE; CYTOKINE 1A TL1A; DEATH RECEPTOR 5; T-CELL;

D O I：

10.1038/nrd3930

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Inhibitors of tumour necrosis factor (TNF) are among the most successful protein-based drugs (biologics) and have proven to be clinically efficacious at reducing inflammation associated with several autoimmune diseases. As a result, attention is focusing on the therapeutic potential of additional members of the TNF superfamily of structurally related cytokines. Many of these TNF-related cytokines or their cognate receptors are now in preclinical or clinical development as possible targets for modulating inflammatory diseases and cancer as well as other indications. This Review focuses on the biologics that are currently in clinical trials for immune-related diseases and other syndromes, discusses the successes and failures to date as well as the expanding therapeutic potential of modulating the activity of this superfamily of molecules.

引用

页码：147 / 168

页数：22

共 220 条

[71] Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates. [J].

Haanstra, KG ;

Ringers, J ;

Sick, EA ;

Ramdien-Murli, S ;

Kuhn, EM ;

Boon, L ;

Jonker, M .

TRANSPLANTATION, 2003, 75 (05) :637-643

[72] Clinical association of serum CD137 (4-1BB) levels in patients with systemic sclerosis [J].

Hamaguchi, Yasuhito ;

Hasegawa, Minoru ;

Matsushita, Takashi ;

Komura, Kazuhiro ;

Takehara, Kazuhiko ;

Fujimoto, Manabu .

JOURNAL OF DERMATOLOGICAL SCIENCE, 2009, 53 (02) :159-161

[73]

Hartung Hans-Peter, 2010, Ther Adv Neurol Disord, V3, P205, DOI 10.1177/1756285610371146

[74] A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma [J].

Haybaeck, Johannes ;

Zeller, Nicolas ;

Wolf, Monika Julia ;

Weber, Achim ;

Wagner, Ulrich ;

Kurrer, Michael Odo ;

Bremer, Juliane ;

Iezzi, Giandomenica ;

Graf, Rolf ;

Clavien, Pierre-Alain ;

Thimme, Robert ;

Blum, Hubert ;

Nedospasov, Sergei A. ;

Zatloukal, Kurt ;

Ramzan, Muhammad ;

Ciesek, Sandra ;

Pietschmann, Thomas ;

Marche, Patrice N. ;

Karin, Michael ;

Kopf, Manfred ;

Browning, Jeffrey L. ;

Aguzzi, Adriano ;

Heikenwalder, Mathias .

CANCER CELL, 2009, 16 (04) :295-308

[75] TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies [J].

Hellwig, Christian T. ;

Rehm, Markus .

MOLECULAR CANCER THERAPEUTICS, 2012, 11 (01) :3-13

[76] Blocking the effects of NGF as a route to safe and effective pain relief - fact or fancy? [J].

Hill, Ray .

PAIN, 2011, 152 (10) :2200-2201

[77]

Holmes D, 2012, NAT REV DRUG DISCOV, V11, P337, DOI [10.1038/nrd3732, 10.1038/nrd3733]

[78] A humanized anti-4-1BB monoclonal antibody suppresses antigen-induced humoral immune response in nonhuman primates [J].

Hong, HJ ;

Lee, JW ;

Park, SS ;

Kang, YJ ;

Chang, SY ;

Kim, KM ;

Kim, JO ;

Murthy, KK ;

Payne, JS ;

Yoon, SK ;

Park, MJ ;

Kim, IC ;

Kim, JG ;

Kang, CY .

JOURNAL OF IMMUNOTHERAPY, 2000, 23 (06) :613-621

[79] TRAIL death receptors and cancer therapeutics [J].

Huang, Ying ;

Sheikh, Saeed .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (03) :284-289

[80] A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses [J].

Huntington, Nicholas D. ;

Tomioka, Ryo ;

Clavarino, Chelsea ;

Chow, Anne M. ;

Linares, David ;

Mana, Paula ;

Rossjohn, Jamie ;

Cachero, Teresa G. ;

Qian, Fang ;

Kalled, Susan L. ;

Bernard, Claude C. A. ;

Reid, Hugh H. .

INTERNATIONAL IMMUNOLOGY, 2006, 18 (10) :1473-1485

← 3 4 5 6 7 8 9 10 11 12 →